ClosedBusiness2020 Targeted Translation Research Accelerator Grant Opportunity

2020 Targeted Translation Research Accelerator Grant Opportunity

Australian Government · Australia

This grant opportunity provides funding for an organisation to deliver a Targeted Translation Research Accelerator focused on improving outcomes for diabetes and cardiovascular disease. The funded organisation will run a comprehensive package of research, partnership and commercialisation activities under the Medical Research Future Fund.

Official Grant Page

Funding

Up to $47M

Location

Australia

Who Can Apply

• Must have an active Australian Business Number and be incorporated in Australia • Must be an eligible entity such as a medical research institute, university, corporation, corporate Commonwealth entity, or state or territory government entity • Joint applications are allowed with an eligible lead organisation • Individuals, partnerships, trusts without an incorporated trustee, unincorporated associations, and non-corporate Commonwealth entities are not eligible
To be eligible, applicants must have an Australian Business Number (ABN), be incorporated in Australia, and in accordance with sections 20 and 24 of the Medical Research Future Fund Act 2015 be one of the following entities: a medical research institute, a university, a corporate Commonwealth entity, a corporation (including businesses and not for profits), or a state or territory government entity. Joint applications are encouraged if there is an eligible lead organisation. Individuals, partnerships, unincorporated associations, organisations not included in section 3.1 of the grant opportunity guidelines, trusts (except where an incorporated trustee applies on behalf of a trust), and non-corporate Commonwealth entities are not eligible.

What's Funded

Delivering the Accelerator, establishing two research centres for diabetes and cardiovascular disease, supporting competitive research projects, funding partnership projects to progress drug and device development, investing in early stage therapeutic research targets, and commissioning research to support health and commercial sector transformation.

Expected Outcomes

Improved knowledge and translation into practice to reduce the burden of diabetes and cardiovascular disease, including development of preventive, diagnostic and therapeutic approaches and products, and progress toward commercialisation of novel therapeutics and devices.

Key Information

Applicant Types

companynon_profituniversitylocal_governmentother

Stage

established

Funding Purposes

researchcommercialisationinnovationr_and_d

Keywords

Medical Research Future FundPreventive and Public Health Research Initiativediabetescardiovascular diseasemedical researchtherapeuticsdiagnosticscommercialisation

Frequently Asked Questions

What is the 2020 Targeted Translation Research Accelerator Grant Opportunity?

The 2020 Targeted Translation Research Accelerator Grant Opportunity is a business grant offered by Australian Government in Australia, providing Up to $47M in funding. This grant opportunity provides funding for an organisation to deliver a Targeted Translation Research Accelerator focused on improving outcomes for diabetes and cardiovascular disease. The funded organisation will run a comprehensive package of research, partnership and commercialisation activities under the Medical Research Future Fund.

How much funding does the 2020 Targeted Translation Research Accelerator Grant Opportunity provide?

The 2020 Targeted Translation Research Accelerator Grant Opportunity provides Up to $47M in funding.

Who is eligible for the 2020 Targeted Translation Research Accelerator Grant Opportunity?

• Must have an active Australian Business Number and be incorporated in Australia • Must be an eligible entity such as a medical research institute, university, corporation, corporate Commonwealth entity, or state or territory government entity • Joint applications are allowed with an eligible lead organisation • Individuals, partnerships, trusts without an incorporated trustee, unincorporated associations, and non-corporate Commonwealth entities are not eligible

What activities are funded?

Delivering the Accelerator, establishing two research centres for diabetes and cardiovascular disease, supporting competitive research projects, funding partnership projects to progress drug and device development, investing in early stage therapeutic research targets, and commissioning research to support health and commercial sector transformation.

How do I apply for the 2020 Targeted Translation Research Accelerator Grant Opportunity?

Start by checking your eligibility using the free Beta Docs eligibility checker. If eligible, Beta Docs' AI-powered platform can help you draft, review, and refine your application to maximise your chances of success.

Need help applying?

Beta Docs has helped founders secure $160M+ in competitive grants. Our AI platform drafts compliance-perfect applications — and our expert reviewers make sure you stand out.

Start with Beta DocsBook a free consultation